Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Life Sci ; 189: 29-38, 2017 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-28912045

RESUMEN

The intestinal microbiota is critical for mammalian immune system development and homeostasis. Sulfate-reducing bacteria (SRB) are part of the normal gut microbiota, but their increased levels may contribute to colitis development, likely in association with hydrogen sulfide (H2S) production. Here, we investigated the effects of SRB in the gut immune response in germ-free mice, and in experimental colitis. After 7days of colonization with Desulfovibrio indonesiensis or with a human SRB consortium (from patients with colitis), germ-free mice exhibited alterations in the colonic architecture, with increased cell infiltration in the lamina propria. SRB colonization upregulated the Th17 and Treg profiles of cytokine production/cell activation, in T cells from mesenteric lymph nodes. These alterations were more pronounced in mice colonized with the human SRB consortium, although D. indonesiensis colonization produced higher levels of H2S. Importantly, the colon of C57BL/6 mice with colitis induced by TNBS or oxazolone had increased SRB colonization, and the administration of D. indonesiensis to mice with TNBS-induced colitis clearly exacerbated the alterations in colonic architecture observed in the established disease, and also increased mouse weight loss. We conclude that SRB contribute to immune response activation in the gut and play an important role in colitis development.


Asunto(s)
Colitis/patología , Desulfovibrio/metabolismo , Inflamación/patología , Sulfatos/metabolismo , Animales , Colitis/inmunología , Modelos Animales de Enfermedad , Femenino , Humanos , Inflamación/inmunología , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Oxazolona/toxicidad , Linfocitos T Reguladores/inmunología , Células Th17/inmunología , Ácido Trinitrobencenosulfónico/toxicidad , Pérdida de Peso
2.
Biochim Biophys Acta Mol Basis Dis ; 1863(6): 1183-1194, 2017 06.
Artículo en Inglés | MEDLINE | ID: mdl-28286160

RESUMEN

P2X7 receptor activation contributes to inflammation development in different pathologies. We previously reported that the P2X7 receptor is over-expressed in the gut mucosa of patients with inflammatory bowel disease, and that P2X7 inhibition protects against chemically induced colitis. Here, we investigated in detail the role of the P2X7 receptor in inflammatory bowel disease development, by treating P2X7 knockout (KO) and WT mice with two different (and established) colitis inductors. P2X7 KO mice were protected against gut inflammation induced by 2,4,6-trinitrobenzenesulfonic acid or oxazolone, with no weight loss or gut histological alterations after treatment. P2X7 receptor knockout induced regulatory T cell accumulation in the colon, as evaluated by qRT-PCR for FoxP3 expression and immunostaining for CD90/CD45RBlow. Flow cytometry analysis of mesenteric lymph node cells showed that P2X7 activation (by ATP) triggered regulatory T cell death. In addition, such cells from P2X7 KO mice expressed more CD103, suggesting increased migration of regulatory T cells to the colon (relative to the WT). Our results show that the P2X7 has a key role during inflammation development in inflammatory bowel disease, by triggering the death and retention in the mesenteric lymph nodes of regulatory T cells that would otherwise promote immune system tolerance in the gut.


Asunto(s)
Colitis/inmunología , Inmunidad Mucosa , Enfermedades Inflamatorias del Intestino/inmunología , Mucosa Intestinal/inmunología , Receptores Purinérgicos P2X7/inmunología , Linfocitos T/inmunología , Animales , Colitis/inducido químicamente , Colitis/genética , Colitis/patología , Femenino , Inflamación/inducido químicamente , Inflamación/genética , Inflamación/inmunología , Inflamación/patología , Enfermedades Inflamatorias del Intestino/inducido químicamente , Enfermedades Inflamatorias del Intestino/patología , Mucosa Intestinal/patología , Ratones , Ratones Noqueados , Oxazolona/efectos adversos , Oxazolona/farmacología , Receptores Purinérgicos P2X7/genética , Linfocitos T/patología , Ácido Trinitrobencenosulfónico/toxicidad
3.
Biochim Biophys Acta ; 1820(12): 1867-78, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22951220

RESUMEN

BACKGROUND: Extracellular ATP is an endogenous signaling molecule released by various cell types and under different stimuli. High concentrations of ATP released into the extracellular medium activate the P2X7 receptor in most inflammatory conditions. Here, we seek to characterize the effects of ATP in human intestinal epithelial cells and to evaluate morphological changes in these cells in the presence of ATP. METHODS: We treated human intestinal epithelial cells with ATP and evaluated the effects of this nucleotide by scanning and transmission electron microscopy analysis and calcium measurements. We used flow cytometry to evaluate apoptosis. We collected human intestinal explants for immunohistochemistry, apoptosis by the TUNEL approach and caspase-3 activity using flow cytometry analyses. We also evaluated the ROS production by flow cytometry and NO secretion by the Griess technique. RESULTS: ATP treatment induced changes characteristic of cell death by apoptosis and autophagy but not necrosis in the HCT8 cell line. ATP induced apoptosis in human intestinal explants that showed TUNEL-positive cells in the epithelium and in the lamina propria. The explants exhibited a significant increase of caspase-3 activity when the colonic epithelial cells were incubated with IFN-gamma followed by ATP as compared to control cells. In addition, it was found that antioxidants were able to inhibit both the ROS production and the apoptosis induced by ATP in epithelial cells. GENERAL SIGNIFICANCE: The activation of P2X7 receptors by ATP induces apoptosis and autophagy in human epithelial cells, possibly via ROS production, and this effect might have implications for gut inflammatory conditions.


Asunto(s)
Adenocarcinoma/patología , Adenosina Trifosfato/farmacología , Apoptosis/efectos de los fármacos , Autofagia/efectos de los fármacos , Colon/efectos de los fármacos , Células Epiteliales/efectos de los fármacos , Neoplasias del Íleon/patología , Adenocarcinoma/metabolismo , Western Blotting , Calcio/metabolismo , Caspasa 3/metabolismo , Células Cultivadas , Colon/citología , Colon/metabolismo , Células Epiteliales/metabolismo , Citometría de Flujo , Técnica del Anticuerpo Fluorescente , Humanos , Neoplasias del Íleon/metabolismo , L-Lactato Deshidrogenasa/metabolismo , Macrófagos/citología , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Necrosis , Óxido Nítrico/metabolismo , Especies Reactivas de Oxígeno/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA